WO1993017743A1 - Powder nebulizer apparatus and method of nebulization - Google Patents
Powder nebulizer apparatus and method of nebulization Download PDFInfo
- Publication number
- WO1993017743A1 WO1993017743A1 PCT/US1993/001857 US9301857W WO9317743A1 WO 1993017743 A1 WO1993017743 A1 WO 1993017743A1 US 9301857 W US9301857 W US 9301857W WO 9317743 A1 WO9317743 A1 WO 9317743A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gas
- housing
- nebulizer
- jet member
- gas jet
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
- B05B1/26—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means with means for mechanically breaking-up or deflecting the jet after discharge, e.g. with fixed deflectors; Breaking-up the discharged liquid or other fluent material by impinging jets
- B05B1/262—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means with means for mechanically breaking-up or deflecting the jet after discharge, e.g. with fixed deflectors; Breaking-up the discharged liquid or other fluent material by impinging jets with fixed deflectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
- A61M16/0816—Joints or connectors
- A61M16/0833—T- or Y-type connectors, e.g. Y-piece
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
- A61M16/16—Devices to humidify the respiration air
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B7/00—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas
- B05B7/0012—Apparatus for achieving spraying before discharge from the apparatus
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B7/00—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas
- B05B7/02—Spray pistols; Apparatus for discharge
- B05B7/04—Spray pistols; Apparatus for discharge with arrangements for mixing liquids or other fluent materials before discharge
- B05B7/0416—Spray pistols; Apparatus for discharge with arrangements for mixing liquids or other fluent materials before discharge with arrangements for mixing one gas and one liquid
- B05B7/0483—Spray pistols; Apparatus for discharge with arrangements for mixing liquids or other fluent materials before discharge with arrangements for mixing one gas and one liquid with gas and liquid jets intersecting in the mixing chamber
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
- A61M16/16—Devices to humidify the respiration air
- A61M16/162—Water-reservoir filling system, e.g. automatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/08—Supports for equipment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T137/00—Fluid handling
- Y10T137/4891—With holder for solid, flaky or pulverized material to be dissolved or entrained
Definitions
- the present invention relates to a powder nebulization method and a powder nebulizer apparatus use ⁇ in respiratory therapy and, in particular, to a continuously connected, continuous flow powder nebulizer useful in respiratory therapy to deliver powdered medications.
- Respiratory delivery of medication for these conditions is preferable to oral, intravenous and subcutaneous delivery because it is non-invasive, permits rapid action of medicant, requires a relatively small dosage, is not filtered through the liver of the patient, and produces a low incidence of systemic side effects.
- Nebulized or aerosolized solutions are the preferred method of respiratory delivery of medication; when fragmented into small particles, medicants are more efficiently deposited near sites of medicant activity in the lung.
- Respiratory medications may be delivered to the lungs of the patient as an aerosol of a liquid or a powder.
- Clinical aerosols are currently generated by jet or ultrasonic nebulizers, metered dose inhalers (MDI) and dry powdered inhalers.
- jet nebulizers for the delivery of liquid medication to the lungs
- ultrasonic nebulizers In conventional jet nebulizers, compressed gas from a compressor or hospital air line is passed through a narrow constriction know as a jet. This creates an area of low pressure, and liquid medication from a reservoir is drawn up through a feed tube and fragmented into droplets by the airstream. Only the smallest drops leave the nebulizer directly, while the majority impact on baffles and walls and are returned to the reservoir. Consequently, jet nebulization takes several minutes to complete, depending upon the initial volume.
- nebulizers include low lung deposition related to the use of tidal breathing. A substantial portion of the dose used in a jet nebulizer is retained permanently as a dead or residual volume on baffles and internal walls of the nebulizer chamber and cannot be released. Generally only 2-10% of the dose placed in the nebulizer ever reaches the lung. The consequences are a higher drug dosage and longer administrative time, along with the associated cost and risk of contamination.
- the second type of aerosol generator is a metered dose inhaler (MDI) , which delivers a bolus of more concentrated drug aerosols than the solution commonly available for nebulizers.
- MDI delivery systems require proper administration technique, which includes coordinated actuation of aerosol delivery with inhalation, a slow inhalation of 0.5-0.75 liters per second, a deep breath approaching inspiratory capacity inhalation, and at least 4 seconds of breath holding.
- MDI's can be equipped with devices that automatically couple actuation to inspiratory effort, thus eliminating the need for coordinating hand action with inhalation.
- Devices such as spacers and holding chambers also decrease partial velocity and reduce the number of large particles. Both of these features reduce oral pharyngeal and large airway deposition with a consequent reduction in systemic absorption. Deposition of aerosols from an MDI with a spacer or holding chamber is similar and perhaps better than the deposition of a properly used MDI alone.
- MDI deposition of 10-15% of the metered dose with consequent short treatment time, low cost and increased convenience.
- MDI's cannot be used by patients requiring mechanical ventilation-
- Other disadvantages include the need for patient cooperation, the practical limitations and inconveniences associated with increased dosing requirements due to the typically small dosages " administered with an MDI, the limited number of currently available drugs, and the dependence on fluorocarbons for aerosol generation.
- the third type of aerosol generator is a dry powdered inhaler.
- Dry powdered inhalation devices currently in use are the Spinhaler, the Rotahaler, the Turbuhaler and the disc inhaler. Dry powdered inhalers are breath actuated and usually require a higher inspiratory flow rate than that required for an MDI or a nebulizer. Flow rates of 1-2 liters per second are usually considered optimal, although flow rates as low as 0.5 liters per second may be effective for some dry powdered inhalers. Advantages of dry powdered inhalers include relative ease of administration and the fact that they do not require fluorocarbon propellants. When a dry powdered inhaler is used properly, deposition appears to be similar to that of a properly used MDI.
- powdered inhalers are limited by the dose they can provide and by the number of drugs currently available. Only terbutaline, salbutamol, dexamethasone and chromolyn sodium are available in powder form.
- dry powdered inhalers include the following: a) they are usually not particle size-selective and thus heavy oral pharyngeal deposition may occur; b) high humidity environments may cause clumping of the particles; and c) dry powdered inhalers cannot be used in ventilatory circuits.
- U.S. Patent 4,232,002 discloses procedures for administering antihistamines. Methods disclosed include inhalation by a patient of mist, nebulized spray, or a cloud of fine solid particles. Products for delivery of medication include pressurized canister inhalers, portable dry powder insuffilators using capsules, and nebulizers. The only dry powder delivery system described is a dry powder inhaler using capsules of dry powder in single dose units. The delivery method described involves puncturing a capsule of dry powder medication which is disbursed by means of a turbomixer to be inhaled through a mouth piece. This patent does not address continuous flow or continuous delivery of inhalable medication. It does not enablingly teach or address jet nebulization of powdered solid medications, and does not teach a nebulizer vial which connects to a nebulizer to provide a device for introducing continuous flow.
- U.S. Patent 3,669,113 discloses a method and device for dispensing powdered medication from a perforated container by rotating the container by pneumatic means and causing, the axis of rotation of the container to precess and describe a path of precession which is contained within a generally conical surface of a precession.
- the mechanisms described are based on varying shaft and bearing configurations.
- the method of this patent is said to be especially well suited to delivery of particles less than 80 microns in diameter.
- the patent does not address jet nebulizaticn, continuous flow or continuous nebulization.
- Recent developments in respiration therapy involve aerosolization and delivery of nebulized liquids on a continuous basis over several hours. Such delivery stabilizes the effects of the medication over time, reduces respiratory personnel support time, and reduces the chances of respiratory circuit contamination.
- a liquid nebulizer system comprising a nebulizer attachable nebulizer vial, a large supply vessel, and a fluid delivery system, to be used with a conventional liquid nebulizer.
- the liquid nebulizer system provides for continuous delivery of liquid medication from a large supply vessel into the nebulizer vial which is attached to a conventional nebulizing apparatus, permitting continuous delivery of nebulized liquid medication.
- the present invention alleviates the disadvantages of conventional administration of respiratory medications.
- the invention provides for administration of respiratory medication with less patient coordination than that required by an MDI or dry powdered inhaler, and can be used in ventilatory circuits. No inspiratory flow rate is required of patients.
- a carrier flow rate as low as .5 to 2 liters per minute can be accommodated by the present invention, as opposed to the 6 to 8 liters per minute flow rate required by a liquid nebulizer apparatus.
- the apparatus of the present invention operates without the baffling system which is used in liquid nebulization systems, thereby enabling a larger percentage of medication to be delivered to the patient instead of being retained in the apparatus.
- the percentage of the originally provided medication which is actually delivered to the patient by the apparatus and method of the present invention is typically greater than 20%.
- the size of particles produced by the invention is determined by the intrinsic physical form, e.g., molecular structure of the medicament species, not by the specific apparatus configuration and methodology of the nebulizer as in liquid nebulizer systems. Higher drug dosages can be obtained by use of the present invention than is possible with conventional respiratory medication delivery systems.
- the present invention relates to a method of forming a solid particle dispersion in a carrier gas stream, comprising the steps of:
- the gas stream directed at the particulate solid is passed through a first nozzle, then expanded and passed through a second nozzle where an entrainment structure channels gas from the conical-shaped receptacle to the jet structure, increasing total gas flow and aiding in the production of a gas jet flow stream of desired velocity and pressure characteristics.
- the entrainment structure comprises a chamber defining a plenum, with an entrainment port communicating in gas flow relationship with the interior volume of the housing, and with an outlet port communicating with the second nozzle to cooperatively form a jet structure therewith.
- the present invention relates to a continuous flow powder nebulizer medicant delivery system comprising a jet nebulizer including a conical nebulizer receptacle.
- the nebulizer receptacle provides a reservoir
- the present invention may be used with a ventilator circuit to deliver nebulized powdered medication and gas to patients via an endotracheal tube when necessary for critically ill patients.
- a mouthpiece, mask or other proximal attachment is used to deliver nebulized powdered medicant to voluntary patients.
- the nebulizer device of the present invention comprises a nebulizer housing having a generally conical-shaped or funicular lower housing portion defining an interior volume enclosed by the housing, and a gas jet member, e.g., a nozzle element, at the upper portion of the housing, generally coaxially aligned with the cone-shaped or funicular lower portion.
- the gas jet member extends through the housing, with an upper inlet portion coupleable to a suitable source of compressed carrier gas, and a lower portion of the gas jet member forming a nozzle or discharge structure for directing gas downwardly to the lower extremity of the conical-shaped or funicular lower portion of the nebulizer housing.
- an exit port for discharge of solids- containing carrier gas from the nebulizer housing to an exterior treatment locus.
- the exit port may be suitably coupled to a ventilator or breathing circuit, comprising connecting tubing, as described hereinabove.
- transverse refers to the direction generally perpendicular to the central axis defined by the conical-shaped or funicular lower portion of the nebulizer housing.
- the above- described gas jet member is coaxially disposed in closed flow communication with a second gas jet member, with the second gas jet member having an upper portion defining a receiving volume for receiving carrier gas discharged from the nozzle or discharge end of the first gas jet member.
- the receiving volume is of significantly greater transverse cross-section than the discharge passage of the first gas jet member.
- the second gas jet member defines a lower discharge passage (nozzle portion) which is of substantially reduced transverse cross-section, relative to the receiving volume.
- Gas exiting the second gas jet member passes through an entrainment structure wherein additional gas, which is channeled from the nebulizer receptacle into the entrainment structure through an entrainment port, is entrained in the gas stream being discharged from the second gas jet member. Entrainment of gas from the nebulizer receptacle increases circulatory flow
- the operation of the nebulizer device of the present invention is based on a number of gas physics laws.
- One such principle is the Bernoulli principle, which states that where the forward velocity of a gas increases, its lateral wall pressure decreases with a corresponding increase in forward pressure.
- the jet structure in the nebulizer of the present invention utilizes this principle.
- the first jet wherein the gas flows through a pinhole or other nozzle-forming means, causes a directed flow of carrier gas to issue from the jet. As the gas leaves this jet, the flow is allowed to expand laterally for a very small distance. The flow is then directed into a second jet comprising a nozzle-forming means, causing the flow to undergo a phenomenon described by Toricelli's law, which states that as gas flow meets a
- the molecules must travel faster in a forward direction than they did previously.
- the accelerated gas flow produced according to Toricelli's law is further accelerated by entrainment of gas from the nebulizer receptacle in the gas flow by means of an entrainment structure.
- the principle upon which such entrainment is based is Venturi's law of air/liquid entrainment.
- gas is directed by the nebulizer through a jet where the gas flow accelerates; in the preferred double-jet system of the invention, this accelerated gas flow then partially re-expands after exiting the jet, and flows into a second jet which further increases the pressure.
- the pressure of the gas being discharged from the second jet entrains gas through the entrainment structure, which increases the circulatory flow of the carrier gas.
- the pressurized gas is directed down into the nebulizer vial with a "V" or cone- shaped apex containing powdered medication. This creates a swirling effect in the receptacle, causing the medication to rise to the top of the nebulizer receptacle for efficient entrainment in the carrier gas and subsequent delivery to the patient.
- Figure 1 is a schematic representation of a patient receiving respiratory support and continuous medication via a continuous flow nebulizing device connected to an
- Figure 2 is a perspective view of a nebulizer housing and supporting system comprising a nebulizer upper portion, nebulizer receptacle and influent gas flow regulating and supply devices.
- Figure 3 is a cross section of a powder nebulizer device comprising an influent port, outlet port, and jet-producing structure.
- Figure 4 is a cross section of a powder nebulizer device comprising an influent port, outlet port, jet-producing structure, and entrainment structure.
- the present invention provides a method and apparatus which overcome the disadvantages associated with currently available respiratory medicant delivery systems.
- the present invention requires less patient coordination than that required by an MDI or dry powdered inhaler, requires no inspiratory flow rate from patients, and can accommodate flow rates for the carrier gas as low as .5 to 2 liters per minute.
- the present invention provides a method and apparatus for continuous respiratory delivery of nebulized powdered medication.
- the present invention provides a metho ' d and apparatus for respiratory delivery of powdered medication which may be used in ventilatory circuits. This represents an advance in the state of the art; no currently
- 15 available devices for delivery of powdered medications in respiratory therapy provide for continuous delivery of nebulized powdered medication or for use with ventilatory circuits.
- proximal is used to indicate the segment of the device normally closest to the patient when it is being used.
- distal refers to the other end.
- nebulizing device is defined to be a nebulizing unit or instrument used to aerosolize powdered medication for delivery to a patient.
- nebulizer receptacle is defined to be that portion of a nebulizing device which comprises a container for' a reservoir for powdered medication to be nebulized.
- nebulizer upper portion is defined to be the non-nebulizer- receptacle portion of the nebulizing device which comprises at least a portion of the nebulizing mechanism.
- a patient 30, undergoing respiratory therapy is fitted with an endotracheal tube 24.
- the proximal trunk end 18 of a "Y"-shaped connector 32 is insertably connected to a distal end 25 of endotracheal tube 24.
- Nebulizing device 48 is connected to arm 34 of "Y"- shaped connector 32 via tube 22 which is interposed and connected between exit port 21 of nebulizer device 48 and arm
- Ventilator 10 distal portion of inhalation respiratory pathway 26 and connects to the output inhalation gas of a ventilator 10.
- Ventilator 10 thereby supplies periodic, breath-sustaining pulses of pressurized gas through tube 12 and through arm 34 of "Y"-shaped connector 32 into endotracheal tube 24 and to patient 30.
- the other distal end 36 of "Y"-shaped connector 32 comprises a proximal portion of an exhalation respiratory pathway 28 which further comprises tube 16 which returns exhalation flow to ventilator 10.
- ventilators are known and available in the art. Generally, ventilators which are currently used with nebulizers may be used with the present invention.
- Nebulizer device 48 receives a supply of nebulizing gas from a flow meter 40 along a fluid pathway 26' which passes through a tube 42 interposed and connected between flow meter 40 and a top nebulizer inflow connecting tube 44 ' .
- Flow meter 40 receives a pressurized gas from a gas source 44 through a connecting tube 42'. Gas pressure from gas source 44 is sufficient to provide the volumetric flow for which flow meter 40 is preset.
- Gas source 44 may comprise pressurized oxygen or other breathable gas from the hospital pressurized oxygen delivery system, from a tank of compressed oxygen, a blender, directly from ventilator 10 or from other sources of pressurized gases used in respiratory therapy.
- Flow meters are well known and widely used in the art. Such flow meters may comprise macro and vernier adjustable
- source 44 may supply oxygen blended with other gases.
- Nebulizing device 48 comprises nebulizer upper portion 20 and a nebulizer receptacle 50. Nebulizing device 48 nebulizes or aerosolizes powdered medication contained in nebulizer receptacle 50 thereby producing a mist (particulate solids-in-gas dispersion) which is carried to patient 30 by influent flow of gas from ventilator 10 through pathway 26' and by nebulizing gas received from gas source 44.
- nebulizing device 48 comprises nebulizer receptacle 50 which is attached to nebulizer upper portion 20.
- the top of the nebulizer receptacle 50 is 1.5 inches in diameter
- the bottom is 0.25 inches in diameter
- the nebulizer receptacle 50 measures 1.5 inches from top to bottom.
- An end 68 of nozzle 66 is disposed above the surface of a reservoir 72 in the bottom of the nebulizer receptacle 50.
- Figure 3 provides a sectional view of nebulizing device 48, comprising nebulizer upper portion 20 and nebulizer receptacle 50.
- nebulizer upper portion 20 is provided for a general understanding of the interaction between nebulizer upper portion 20 and nebulizer receptacle 50.
- the nebulizer upper portion 20, as seen in Figure 3, comprises a housing 262 which includes a nebulizer inflow connecting tube 44', a nozzle 260, and a second nozzle 66.
- the jet structure comprising the nozzles may, as shown, be positioned off-center relative to the centerline axis L-L of the receptacle.
- the jet structure may be offset to the receptacle centerline (vertical axis) or the jet structure may be coaxial with such central axis of the receptacle, depending on the overall design, operation, and end use application of the nebulizer.
- Pressurized gas which provides the nebulizing high velocity gas stream for nebulization is provided through nebulizer inflow connecting tube 44'.
- the high velocity stream is produced by nozzle 260 and nozzle 66.
- the pressurized gas is discharged from the first nozzle 260 into the receiving volume 65 of the second nozzle 66, thereby undergoing expansion, following which the gas is discharged
- nebulizer upper portion 20 is for a single connecting tube 44', nozzle 260, nozzle 66 and associated parts, the type, number, and structure of inflow connecting tubes, nozzles, and associated nebulizer parts may vary.
- Nebulizer receptacle 50 has a conical-shaped or funicular shape, is made from synthetic resinous material and is preferably transparent or at least translucent for easy monitoring of solids content by a respiratory technician or other patient attendant.
- Various materials of construction which are well known in the art are appropriate for the nebulizer receptacle- They are usually of chemically-inert thermoplastic such as polyolefins or polyvinyl chlorides. Their selection and fabrication are well within the skill of the art.
- Apex 78 of the conical-shaped nebulizer receptacle 50 provides a containment structure for powdered medication contained in nebulizer receptacle 50.
- a plurality of legs 80 provide a level support when nebulizer receptacle 50 is disposed on a. horizontal surface, to maintain powdered
- Figure 4 provides a sectional view of nebulizing device 148, comprising nebulizer upper portion 120 and nebulizer receptacle 150.
- Numerals in Figure 4 have been differentiated from numerals designating like parts in Figure 3 by adding 100 to each such numeral.
- the nebulizer upper portion 120 comprises a housing 362 which includes a nebulizer inflow connecting tube 144', a first nozzle 360, and a second nozzle 166.
- Pressurized gas is provided through nebulizer inflow connecting tube 144'.
- the high velocity stream of gas for nebulization is produced by nozzle 360 and nozzle 166.
- the pressurized gas is discharged from the first nozzle 360 into the receiving volume 165 of the second nozzle 166, thereby undergoing expansion, following which the gas is discharged into entrainment structure 167.
- a resulting below ambient pressure within entrainment structure 167 creates a sufficient pressure differential between entrainment port 169 and nebulizer receptacle 150 to draw gas from nebulizer receptacle 150 through entrainment port 169 and into entrainment structure 167 where the entrained gas is added to the high velocity gas stream being directed toward reservoir 172.
- the resultingly augmented gas stream exits entrainment structure 167 through outlet port 170.
- the high velocity gas stream thus discharged from jet structure 171 engages the powdered medication in the lower portion of
- nebulizer receptacle 150 which is of progressively decreasing transverse cross-section. As a result, there is achieved a high extent of solids entrainment in the gas stream, as discharged into inhalation pathway 126' via exit port 121.
- the powder nebulizer apparatus of the invention is generally configured as shown and described with reference to Figures 3 or 4 hereof, and such nebulizer device is utilized for delivery of dry powder medicament.
- the nebulizer device is configured as shown and described with reference to Figure 4 hereof.
- such nebulizer device is provided with an oxygen-containing carrier gas which is introduced into the powder-containing receptacle of the device at a flow rate in the range of from about 0.5 to 2 liters per minute, thereby producing a solids-in-gas disperson which is flowed by suitable connector structure from the nebulizer device to the patient, to effect treatment of the patient with the powder medicament.
- the nebulizer housing is formed of a transparent or transluscent polymeric material, e.g., of thermoplastic construction, so that visual verification of
- the nebulizer device of the present invention is usefully employed in the delivery of powdered medication to the lungs for treatment of a patient.
- powdered medicament delivery facilitates administration of the treatin agent where it is insoluble in suitable liquids for conventional liquid aerosolization, and the dry powder form of the delivered medicament enables lower fluid volumes to be administered to the patient undergoing treatment.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5515829A JPH07504344A (en) | 1992-03-04 | 1993-03-03 | Powder medicine spray equipment and spray method |
EP93906275A EP0630271A1 (en) | 1992-03-04 | 1993-03-03 | Powder nebulizer apparatus and method of nebulization |
AU37367/93A AU659727B2 (en) | 1992-03-04 | 1993-03-03 | Powder nebulizer apparatus and method of nebulization |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/846,784 US5186166A (en) | 1992-03-04 | 1992-03-04 | Powder nebulizer apparatus and method of nebulization |
US846,784 | 1992-03-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993017743A1 true WO1993017743A1 (en) | 1993-09-16 |
Family
ID=25298940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/001857 WO1993017743A1 (en) | 1992-03-04 | 1993-03-03 | Powder nebulizer apparatus and method of nebulization |
Country Status (6)
Country | Link |
---|---|
US (1) | US5186166A (en) |
EP (1) | EP0630271A1 (en) |
JP (1) | JPH07504344A (en) |
AU (1) | AU659727B2 (en) |
CA (1) | CA2130827C (en) |
WO (1) | WO1993017743A1 (en) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6540154B1 (en) * | 1991-04-24 | 2003-04-01 | Aerogen, Inc. | Systems and methods for controlling fluid feed to an aerosol generator |
US6681767B1 (en) * | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
ATE359842T1 (en) * | 1991-07-02 | 2007-05-15 | Nektar Therapeutics | DISPENSING DEVICE FOR MIST-FORMED MEDICATIONS |
US5476093A (en) * | 1992-02-14 | 1995-12-19 | Huhtamaki Oy | Device for more effective pulverization of a powdered inhalation medicament |
US5355872B1 (en) * | 1992-03-04 | 1998-10-20 | John H Riggs | Low flow rate nebulizer apparatus and method of nebulization |
US5785049A (en) * | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
GB2273660B (en) * | 1992-09-11 | 1996-07-17 | Aid Medic Ltd | Drug delivery arrangement |
EP0590289A1 (en) * | 1992-09-28 | 1994-04-06 | Engström Medical Ab | Patient connector |
US6024090A (en) * | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
WO1994028921A1 (en) * | 1993-06-04 | 1994-12-22 | Demeter Biotechnologies, Ltd. | Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides |
US5773413A (en) * | 1993-06-04 | 1998-06-30 | Demeter Biotechnologies, Ltd. | Method of combating mammalian neoplasias, and lytic peptides therefor |
US5561107A (en) * | 1993-06-04 | 1996-10-01 | Demeter Biotechnologies, Ltd. | Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides |
US6729334B1 (en) * | 1994-06-17 | 2004-05-04 | Trudell Medical Limited | Nebulizing catheter system and methods of use and manufacture |
NZ272354A (en) * | 1994-06-17 | 1997-10-24 | Trudell Medical Ltd | Catheter system; method and apparatus for delivering an aerosol form of medication to the lungs, details of method and of catheter apparatus |
US5642730A (en) * | 1994-06-17 | 1997-07-01 | Trudell Medical Limited | Catheter system for delivery of aerosolized medicine for use with pressurized propellant canister |
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
WO1996009085A1 (en) * | 1994-09-21 | 1996-03-28 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US5611332A (en) * | 1995-03-22 | 1997-03-18 | Bono; Michael | Aerosol inhalation device containing a rain-off chamber |
US6782886B2 (en) | 1995-04-05 | 2004-08-31 | Aerogen, Inc. | Metering pumps for an aerosolizer |
US6205999B1 (en) | 1995-04-05 | 2001-03-27 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
US6014970A (en) * | 1998-06-11 | 2000-01-18 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
US5758637A (en) | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US5654007A (en) * | 1995-06-07 | 1997-08-05 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
EP0862474A4 (en) * | 1995-09-18 | 2000-05-03 | Resmed Ltd | Pressure control in cpap treatment or assisted respiration |
CA2212430A1 (en) | 1997-08-07 | 1999-02-07 | George Volgyesi | Inhalation device |
US6257233B1 (en) * | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
US6235177B1 (en) | 1999-09-09 | 2001-05-22 | Aerogen, Inc. | Method for the construction of an aperture plate for dispensing liquid droplets |
US6679256B2 (en) | 1999-12-17 | 2004-01-20 | Nektar Therapeutics | Systems and methods for extracting powders from receptacles |
US6948491B2 (en) * | 2001-03-20 | 2005-09-27 | Aerogen, Inc. | Convertible fluid feed system with comformable reservoir and methods |
US8336545B2 (en) * | 2000-05-05 | 2012-12-25 | Novartis Pharma Ag | Methods and systems for operating an aerosol generator |
MXPA02010884A (en) * | 2000-05-05 | 2003-03-27 | Aerogen Ireland Ltd | Apparatus and methods for the delivery of medicaments to the respiratory system. |
US7600511B2 (en) * | 2001-11-01 | 2009-10-13 | Novartis Pharma Ag | Apparatus and methods for delivery of medicament to a respiratory system |
US7100600B2 (en) * | 2001-03-20 | 2006-09-05 | Aerogen, Inc. | Fluid filled ampoules and methods for their use in aerosolizers |
US7971588B2 (en) * | 2000-05-05 | 2011-07-05 | Novartis Ag | Methods and systems for operating an aerosol generator |
US6543443B1 (en) | 2000-07-12 | 2003-04-08 | Aerogen, Inc. | Methods and devices for nebulizing fluids |
GB0022285D0 (en) * | 2000-09-09 | 2000-10-25 | Viamed Ltd | Breathing aid device |
WO2002026223A2 (en) * | 2000-09-29 | 2002-04-04 | Board Of Trustees Operating Michigan State University | Catecholamine pharmaceutical compositions and methods |
AUPR315401A0 (en) * | 2001-02-16 | 2001-03-15 | Resmed Limited | An apparatus for supplying clean breathable gas |
US6546927B2 (en) | 2001-03-13 | 2003-04-15 | Aerogen, Inc. | Methods and apparatus for controlling piezoelectric vibration |
US6550472B2 (en) | 2001-03-16 | 2003-04-22 | Aerogen, Inc. | Devices and methods for nebulizing fluids using flow directors |
US6732944B2 (en) * | 2001-05-02 | 2004-05-11 | Aerogen, Inc. | Base isolated nebulizing device and methods |
US6554201B2 (en) | 2001-05-02 | 2003-04-29 | Aerogen, Inc. | Insert molded aerosol generator and methods |
US20050205089A1 (en) * | 2002-01-07 | 2005-09-22 | Aerogen, Inc. | Methods and devices for aerosolizing medicament |
US7677467B2 (en) * | 2002-01-07 | 2010-03-16 | Novartis Pharma Ag | Methods and devices for aerosolizing medicament |
WO2003057291A1 (en) | 2002-01-07 | 2003-07-17 | Aerogen, Inc. | Devices and methods for nebulizing fluids for inhalation |
WO2003059424A1 (en) | 2002-01-15 | 2003-07-24 | Aerogen, Inc. | Methods and systems for operating an aerosol generator |
US6705316B2 (en) | 2002-03-11 | 2004-03-16 | Battelle Pulmonary Therapeutics, Inc. | Pulmonary dosing system and method |
DE60330761D1 (en) * | 2002-04-19 | 2010-02-11 | 3M Innovative Properties Co | SPACE FOR THE EARLY REMOVAL OF THE NONINSTATABLE SHARE OF A MEDICAL AEROSOL |
US7607436B2 (en) * | 2002-05-06 | 2009-10-27 | The Research Foundation Of State University Of New York | Methods, devices and formulations for targeted endobronchial therapy |
US7334580B2 (en) * | 2002-05-07 | 2008-02-26 | Smaldone Gerald C | Methods, devices and formulations for targeted endobronchial therapy |
US6915962B2 (en) * | 2002-05-20 | 2005-07-12 | Aerogen, Inc. | Apparatus for providing aerosol for medical treatment and methods |
US20070044792A1 (en) * | 2005-08-30 | 2007-03-01 | Aerogen, Inc. | Aerosol generators with enhanced corrosion resistance |
EP1558312B1 (en) * | 2002-06-28 | 2017-08-09 | The Research Foundation of the State University of New York | Therapeutic agent delivery device and method |
US20040121003A1 (en) * | 2002-12-19 | 2004-06-24 | Acusphere, Inc. | Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
US8616195B2 (en) * | 2003-07-18 | 2013-12-31 | Novartis Ag | Nebuliser for the production of aerosolized medication |
WO2005042079A1 (en) * | 2003-10-31 | 2005-05-12 | Trudell Medical International | System and method for manipulating a catheter for delivering a substance to a body cavity |
WO2005051177A2 (en) * | 2003-11-25 | 2005-06-09 | Coifman Robert E | Devices for measuring inspiratory airflow |
CA2561403C (en) * | 2004-04-20 | 2015-12-01 | Aerogen, Inc. | Aerosol delivery apparatus for pressure assisted breathing |
US7290541B2 (en) * | 2004-04-20 | 2007-11-06 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
US7267121B2 (en) * | 2004-04-20 | 2007-09-11 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
US7946291B2 (en) | 2004-04-20 | 2011-05-24 | Novartis Ag | Ventilation systems and methods employing aerosol generators |
DE102004043411B3 (en) * | 2004-09-02 | 2006-05-04 | Weitmann & Konrad Gmbh & Co Kg | Apparatus and method for producing a powder-air mixture |
GB0427028D0 (en) * | 2004-12-09 | 2005-01-12 | Cambridge Consultants | Dry powder inhalers |
DE102005016229B3 (en) | 2005-04-08 | 2006-06-14 | Altana Pharma Ag | Dry atomizer, useful for atomizing a medicament preparation, comprises a housing, a gas pipeline with gas inlet, and a gas deflection with gas outlet, which acts as a filter |
DE102005016230A1 (en) * | 2005-04-08 | 2006-10-19 | Altana Pharma Ag | Device for dry fogging |
EA012656B1 (en) * | 2005-05-25 | 2009-12-30 | Аэроджен, Инк. | Vibration systems and use thereof |
CN101489613A (en) * | 2006-07-14 | 2009-07-22 | 阿斯利康(瑞典)有限公司 | Inhalation system and delivery device for the administration of a drug in the form of dry powder |
JP2008199905A (en) * | 2007-02-16 | 2008-09-04 | Snow Brand Milk Prod Co Ltd | Improving agent for survivability of lactic acid bacterium |
EP2157992B1 (en) * | 2007-06-15 | 2016-12-14 | iDTx Systems, Inc. | A drug delivery and monitoring system for a ventilator |
US20090050141A1 (en) * | 2007-08-21 | 2009-02-26 | Russell Wayne King | Pre-filled, single-use, disposable small volume medication nebulizer |
US20090211576A1 (en) * | 2007-10-02 | 2009-08-27 | Timo Lehtonen | Safety and abuse deterrent improved device |
AU2008326425B2 (en) * | 2007-11-19 | 2012-04-26 | Sunmed Group Holdings, Llc | Patient interface assembly for respiratory therapy |
PL2337600T3 (en) | 2008-09-26 | 2020-04-30 | Stamford Devices Limited | Supplemental oxygen delivery system |
WO2012020004A1 (en) * | 2010-08-09 | 2012-02-16 | Nycomed Gmbh | Device and system for delivery of an aerosol to a patient on ventilatory support |
US9032951B2 (en) | 2010-08-24 | 2015-05-19 | Trudell Medical International | Aerosol delivery device |
AT510585B1 (en) * | 2010-11-18 | 2012-05-15 | Apeptico Forschung & Entwicklung Gmbh | COMPOSITION COMPRISING A PEPTIDE AND AN INHIBITOR OF VIRAL NEURAMINIDASE |
US20140207016A1 (en) | 2011-01-20 | 2014-07-24 | Pneumoflex Systems, Llc | Pulsed nebulizer |
US9452270B2 (en) | 2011-01-20 | 2016-09-27 | Pneumoflex Systems, Llc | Nebulizer having replaceable nozzle assembly and suction line |
WO2013181459A1 (en) * | 2012-05-30 | 2013-12-05 | The University Of Kansas | Inhalation device, systems, and methods for administering powdered medicaments to mechanically ventilated subjects |
CN103203061A (en) * | 2013-03-11 | 2013-07-17 | 杭州莱克思大医疗用品有限公司 | Novel oxygen humidifying device |
JP6480598B2 (en) | 2015-04-02 | 2019-03-13 | ヒル−ロム サービシーズ プライヴェート リミテッド | Respirator manifold |
GB201704999D0 (en) * | 2017-03-29 | 2017-05-10 | British American Tobacco Investments Ltd | Aerosol delivery system |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1599959A (en) * | 1923-03-23 | 1926-09-14 | Fujimoto Buheiji | Atomizer |
US2693805A (en) * | 1947-03-08 | 1954-11-09 | George V Taplin | Apparatus for administering therapeutic agents |
US2870565A (en) * | 1957-02-28 | 1959-01-27 | Warren S Martin | Powder-disseminating device |
US4510929A (en) * | 1982-04-30 | 1985-04-16 | Bordoni Maurice E | Disposable radioactive aerosol inhalation apparatus |
US4662799A (en) * | 1985-05-17 | 1987-05-05 | Fuller Company | Apparatus and process for pneumatically conveying particulate material |
US5086765A (en) * | 1990-08-29 | 1992-02-11 | Walter Levine | Nebulizer |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2792971A (en) * | 1955-03-03 | 1957-05-21 | Haloid Co | Particle aerosol generation |
US2820565A (en) * | 1956-10-05 | 1958-01-21 | Nat Hardware Corp | Lockable bottle or like container |
US3353873A (en) * | 1966-07-11 | 1967-11-21 | Dietert Co Harry W | Valve structure for bulk materials |
DE1813993C3 (en) * | 1968-12-11 | 1974-01-24 | Paul Ritzau Pari-Werk Kg, 8135 Soecking | Device for atomizing and atomizing liquid or powdery substances |
FI64896C (en) * | 1978-04-18 | 1984-02-10 | Taisto Haekkinen | RESPIRATOR |
SU835910A1 (en) * | 1979-07-09 | 1981-06-07 | Государственный Проектный Институт "Ярос-Лавский Промстроипроект" | Chamber feeder of pneumatic conveying unit |
US4823784A (en) * | 1982-04-30 | 1989-04-25 | Cadema Medical Products, Inc. | Aerosol inhalation apparatus |
US4703753A (en) * | 1982-04-30 | 1987-11-03 | Cadema Medical Products, Inc. | Radioactive aerosol inhalation apparatus |
DE3429389C1 (en) * | 1984-08-09 | 1986-03-13 | Brugger, Inge, geb. Ritzau, 8130 Starnberg | Inhaler |
JPH0614786B2 (en) * | 1984-12-28 | 1994-02-23 | 富士電機株式会社 | PWM signal generation circuit |
SU1418218A1 (en) * | 1986-07-18 | 1988-08-23 | Производственное Объединение "Ворошиловградский Тепловозостроительный Завод Им.Октябрьской Революции" | Chamber feeder |
DK479189D0 (en) * | 1989-01-06 | 1989-09-28 | Hans Gernot Schenk | INHALER |
GB2233919A (en) * | 1989-07-12 | 1991-01-23 | Stephen Peter Newman | "Aerosol delivery apparatus" |
-
1992
- 1992-03-04 US US07/846,784 patent/US5186166A/en not_active Expired - Lifetime
-
1993
- 1993-03-03 AU AU37367/93A patent/AU659727B2/en not_active Ceased
- 1993-03-03 CA CA 2130827 patent/CA2130827C/en not_active Expired - Fee Related
- 1993-03-03 WO PCT/US1993/001857 patent/WO1993017743A1/en not_active Application Discontinuation
- 1993-03-03 EP EP93906275A patent/EP0630271A1/en not_active Withdrawn
- 1993-03-03 JP JP5515829A patent/JPH07504344A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1599959A (en) * | 1923-03-23 | 1926-09-14 | Fujimoto Buheiji | Atomizer |
US2693805A (en) * | 1947-03-08 | 1954-11-09 | George V Taplin | Apparatus for administering therapeutic agents |
US2870565A (en) * | 1957-02-28 | 1959-01-27 | Warren S Martin | Powder-disseminating device |
US4510929A (en) * | 1982-04-30 | 1985-04-16 | Bordoni Maurice E | Disposable radioactive aerosol inhalation apparatus |
US4662799A (en) * | 1985-05-17 | 1987-05-05 | Fuller Company | Apparatus and process for pneumatically conveying particulate material |
US5086765A (en) * | 1990-08-29 | 1992-02-11 | Walter Levine | Nebulizer |
Also Published As
Publication number | Publication date |
---|---|
CA2130827A1 (en) | 1993-09-16 |
US5186166A (en) | 1993-02-16 |
AU659727B2 (en) | 1995-05-25 |
JPH07504344A (en) | 1995-05-18 |
CA2130827C (en) | 1996-05-21 |
AU3736793A (en) | 1993-10-05 |
EP0630271A1 (en) | 1994-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5186166A (en) | Powder nebulizer apparatus and method of nebulization | |
US5355872A (en) | Low flow rate nebulizer apparatus and method of nebulization | |
JP3230056B2 (en) | Device for forming an aerosolized dose of a drug | |
US6681767B1 (en) | Method and device for delivering aerosolized medicaments | |
US6116239A (en) | Inhalation device | |
US6085742A (en) | Intrapulmonary delivery device | |
CN1956745B (en) | Aerosol delivery apparatus for pressure-assisted breathing systems | |
US20080115785A1 (en) | Inhalers | |
JP2000504603A (en) | Nebulizer device and method | |
O'Callaghan | Delivery systems: the science | |
O'Callaghan et al. | The effects of Heliox on the output and particle-size distribution of salbutamol using jet and vibrating mesh nebulizers | |
RU2258539C1 (en) | Powder inhaler | |
GB2233919A (en) | "Aerosol delivery apparatus" | |
Corcoran et al. | Medical atomization design for inhalation therapy | |
Shilla | Aerosol Therapy in Pediatrics: is it helpful? | |
CA2531251A1 (en) | Nebulizer for aerosol drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2130827 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993906275 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1993906275 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993906275 Country of ref document: EP |